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Abstract
Taurine possesses membrane stabilization, osmoregulatory and antioxidant properties, aspects of relevance to
ischemic injury. We tested the hypothesis that body taurine status is a determinant of renal ischemic injury.
Accordingly, renal function and structure were examined in control (C), taurine-treated (TT) and taurine deficient
(TD) rats that were subjected to bilateral renal ischemia (60 min) followed by reperfusion (IR); sham operated rats
served as controls. Baseline urine osmolality was greater in the TD group than in the control and the TT groups, an
effect associated with increased renal aquaporin 2 level. The IR insult reduced urine osmolality (i.e., day-1 post
insult); the TD/IR group displayed a more marked recovery in urine osmolality by day-6 post insult than the other
two groups. Fluid and sodium excretions were lower in the TD/IR group, suggesting propensity to retention. Histo-
pathological examination revealed the presence of tubular necrotic foci in the C/IR group than sham controls.
While renal architecture of the TD/IR group showed features resembling sham controls, the TT/IR group showed
dilated tubules, which lacked immunostaining for aquaporin 2, but not 1, suggestive of proximal tubule origin.
Finally, assessment of cell proliferation and apoptosis revealed lower proliferation but higher apoptotic foci in the
TT/IR group than other IR groups. Collectively, the results indicate that body taurine status is a major determinant
of renal IR injury.
Introduction
Acute renal failure is a potentially reversible condition
with the hallmark feature of impaired ability of the kid-
ney to eliminate waste products and maintain fluid and
electrolyte balance. It describes a syndrome of disorders
that are classified into three categories: pre-renal (e.g.,
due to a reduction in glomerular perfusion), post-renal
(e.g., due to obstruction to urine flow) and intrinsic
(e.g., due to tubular necrosis). Importantly, intrinsic
acute tubular necrosis is most commonly attributable to
ischemic injury which accounts for about 50% of the
cases of acute renal failure [1,2]. Examples of clinical
conditions associated with renal ischemia reperfusion
(IR) injury include renal transplantation, partial
nephrectomy and repair of some forms of abdominal
aneurysms. Indeed, despite great strides, renal IR injury
associated with transplantation contributes importantly
to delayed graft function, delayed graft rejection, acute
rejection and chronic allograft nephropathy [3-5].
Acute renal IR injury is a highly coordinated process
that is mediated by components of both the innate and
adaptive arms of immunity, which determine both the
early phase and long-term functional outcome [6-11].
The ischemic insult increases endothelium permeability
and expression of adhesion molecules that are crucial
for recruitment and infiltration of inflammatory cells
into the post-ischemic region. Further, activation of
transcription factors (e.g., nuclear factor B) causes
upregulation of inflammatory genes [6]. Upon reperfu-
sion, the ischemic-primed endothelial cells are prone to
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in further enhancement of endothelial cell permeability
and cell activation. In turn, leukocytes serve as a source
of reactive oxygen species and a variety of cytokines,
which further exacerbate the inflammatory process.
These processes, coupled with IR injury-induced loss of
cellular energy and consequent derangement of ionic
homeostasis ultimately lead to cell death [6-10]. Proxi-
mal tubular cells, a prime target of IR injury, swell, lose
brush borders and develop cytoskeletal abnormalities,
including abnormal localization of cell membrane com-
ponents (e.g., translocation of the Na
+-K
+-ATPase from
the basolateral sites to the cytoplasm/apical sites of the
tubular cells) [7-9,11]. Functional consequences include
decreased tubular reabsorption of sodium, as reflected
by the increase in fractional excretion of sodium [10].
Indeed, as a result of the enhanced delivery of solutes to
the macula densa, the tubuloglomerular feedback
mechanism is activated leading to a persistent constric-
tion of the afferent arterioles and a consequent reduc-
tion in the glomerular filtration rate [1,7,10]. Another
functional hallmark of renal IR injury is marked impair-
ment in urinary concentrating ability, which is further
evidence for the dysregulation of tubular fluid and of
solute transport [10]. Histological examination of the
kidney reveals tubules surrounded by flattened, denuded
epithelium containing lumen filled by cell debris; peri-
tubular capillaries are congested and display extensive
inflammatory infiltrates [1,2,7].
Interestingly, renal tubule cells possess a remarkable
ability to regenerate and proliferate following an
ischemic injury [1,7,9]. Whi l es o m eh a v ei m p l i c a t e d
mesenchymal stem cells (resident and bone marrow-
derived) in the regeneration of tubule cells [12,13],
others have implicated the dedifferentiation of viable
cells, which subsequently proliferate, differentiate and
establish polarity, thereby restoring normal structure
and function [8,11]. The return of glomerular filtration
contributes to the removal of tubular debris to minimize
obstruction. A period may exist in which glomerular fil-
tration has normalized but tubular function remains
deranged. This period underlies the polyuric phase of
acute tubular necrosis associated with hypoosmotic
polyuria. Indeed, it has been suggested that severe
ischemic injury results in permanent alterations in renal
capillary density that not only contributes to the urinary
concentrating deficit but also predisposes to the devel-
opment of later complications (e.g. altered sodium
homeostasis, propensity to hypertension and secondary
renal disease) [2,3,10].
The marked adverse impact of IR injury on the kidney
necessitates identification of effective maneuvers and
therapies aimed at preventing and limiting tissue injury.
Taurine is shown to exert a number of cytoprotective
effects that could potentially benefit the ischemic reper-
fused kidney. These include its purported antioxidant,
membrane stabilizing, cellular osmoregulatory and antia-
poptotic effects [14-17]. In addition, we have shown that
taurine is an important modulator/ regulator of renal
function and therefore a contributor to body fluid and
electrolyte homeostasis [18-21]. Thus we conjectured
that body taurine status is an important determinant of
the outcome of renal IR injury. Accordingly, we have
examined the impact of taurine supplementation and
deficiency on the outcome of a bilateral renal IR insult
in rat.
Methods
Preparation of experimental groups
A) Animals: Male Sprague-Dawley rats (8-9 weeks of
age) were obtained from Harlan laboratories (Indianapo-
lis, Indiana). The use of animals in this study was in
accordance with the NIH guide on Humane Treatment
of Laboratory Animals. Two days after arrival, the ani-
mals were randomly assigned to receive tap water (con-
trol), tap water containing 1% taurine or tap water
containing 3% b-alanine for 2 weeks; the b-alanine regi-
men reduces renal tissue taurine content by about 50%
[21]. The animals had free access to drinking fluid and
food (Harlan Teklad diet 8604) throughout the study.
B) Bilateral ischemia reperfusion injury: Two weeks
after initiation of the treatment regimens, and collection
of baseline excretion data (below), each rat was sub-
jected to one hour of bilateral renal ischemia [10,3].
Under pentobarbital anesthesia (40-45 mg/kg; i.p.), two
flank incisions were made in areas corresponding to
each kidney. Ischemia was induced by application of a
nontraumatic clamp to each renal pellicle for a period
of 60 minutes followed by removal of the clamp to
allow continued perfusion that was verified visually
before closure of surgical sites. Sham-operated control
animals were subjected to the same procedure whereby
each kidney was gently manipulated but was not sub-
jected to ischemia. The muscle layers and the skin inci-
sions were closed with sterile silk sutures and autoclips,
respectively; postoperative analgesia was provided with
butorphanol (2 mg/kg; twice daily for one day). Thus
the protocol outlined above produced four experimental
groups (n=5-7 animals/ group) as follows: sham control,
ischemic-reperfused (IR) control (C/IR), taurine deficient
(TD) ischemic-reperfused (TD/IR) and taurine-treated
(TT) ischemic-reperfused (TT/IR). Once fully awake,
each animal was returned to its metabolic cage and
daily urine samples collected for 6 consecutive days.
Renal function studies
A) Prior to bilateral IR injury, the animals were placed
individually in metabolic cages. After a period of two
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ples were collected and used for determination of base-
line renal functional parameters [19-21]. Following the
surgical procedure to induce IR injury, and full recovery
of consciousness, the animals were returned to their
metabolic cages and daily urine samples collected for
6 days.
B) Following daily metabolic studies, the animals
were implanted with femoral vessels and bladder
catheters in preparation for acute renal function stu-
dies. Accordingly, renal responses to an isotonic saline
volume load (5% body weight over 30 min., i.v.; total
of 90 minute post-infusion collection) were determined
in pre-instrumented conscious animal.
3H-Inulin was
used for measurement of the glomerular filtration rate
(GFR) [18-21].
Histopathological studies
Formalin-fixed and paraffin-embedded kidney tissue
blocks were cut in 4 µm sections followed by hematoxy-
lin-eosin (H&E) staining. Immunohistochemical staining
was carried out utilizing aquaporin (AQP) 1 and AQP2
antibodies (rabbit-polyclonal antibodies to AQP1
and AQP2 (Sigma, St. Louis MO) [21,22]. Immuno-
fluoresence staining for proliferating nuclear cell antigen
(PCNA) was achieved with monoclonal mouse anti-
PCNA (Dako, Glostrup, Denmark) for one hour.
Cyanine conjugated horse anti-mouse (Jackson Immu-
noresearch, West Grove, PA) was used for fluorescent
detection. Finally, formalin-fixed, paraffin-embedded
kidney tissues were processed for terminal deoxynucleo-
tidyl transferase dUTP nick end labeling (TUNEL) assay
using the ApopTag Plus Peroxidase in Situ Apoptosis
Detection Kit (Millipore Temecula, CA).
Western blot for AQP 2
Additional groups of control, TD and TT rats (n=3/
group), which were not subjected to ischemic injury,
were used for determination of the potential impact of
body taurine status on (baseline) renal AQP2 expression
[22]. Upon sacrifice, renal tissue was quickly procured
a n ds t o r e di nl i q u i dn i t r o g e n. Thereafter, renal tissue
was powdered using a mortal and pestle (on dry ice).
The tissue powder was added to the isolation buffer
(10mM triethanolamine, 250mM Sucrose, PH 7.6, 1 µg/
ml Leupeptin, PMSF (2 mg/ml), sonicated and sodium
dodecyl sulfate added to a final concentration of 1%
prior to centrifugation; the supernatant was used for
protein assay [22,23]. Standard protocols were used for
Western blot analysis as described previously (i.e., 10%
gel, electrophoretic protein transfer to nitrocellulose
membrane, primary antibody to aquaporin 2, secondary
antibody and detection by enhanced chemiluminescence;
GE Healthcare UK, Buckinghamshire UK) [22]. The
protein expression data were corrected for b-actin and
expressed as percent of the control group.
Assays and urinary protein profile
Sodium and potassium were measured by flame photo-
metry and used to calculate excretion rates. Urine
osmolality was measured by an osmometer and urinary
protein content by the Coomassie blue method (Sigma,
S a i n tL o u i s ,M O ) ;u r i n a r yp r otein profile was deter-
mined using sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) as described previously
[21]. The glomerular filtration rate and fractional excre-
tions of sodium and potassium were calculated using
standard clearance formulas [18-21]. For taurine mea-
surement, renal tissue was homogenized in 2% perchlo-
ric acid (1:10 w/v) and the supernatant used to assay
taurine by a colorimetric method [21].
Statistics
All data were analyzed by the analysis of variance
(ANOVA). Variables that were measured sequentially
were analyzed by repeated measure ANOVA. Duncan’s
post hoc test was used for comparison of mean values
(significance of criteria of p<0.05). Data are reported as
means ± SEM.
Results
Body weight was similar among the groups before the
initiation of the bilateral IR protocol. The TD/IR group
(272 ± 4 g) displayed reduced (p<0.05) body weight
about 10 days after initiation of the IR protocol com-
pared to the sham control (317 ± 5 g), the C/IR group
(318 ± 9 g) and the TT/IR group (310 ± 6 g). Kidney
weight was greater in the TT/IR group (3.7 ± 0.5 g)
than in the sham control (2.7 ± 0.2 g; p<0.05), C/IR
(3.0 ± 0.1 g) and the TD/IR groups (3.3 ± 0.2 g). Kidney
weight to body weight ratios (mg/g) were similar in the
TD/IR (12.3 ± 0.7) and the TT/IR groups (12.3 ± 1.4)
but higher (p<0.05) than either the C/IR (9.8 ± 0.4) or
the sham controls (8.7 ± 0.7). The TD/IR group dis-
played a 25% reduction (p<0.05) in tissue taurine con-
tent (µmoles/g wet tissue weight) compared to the other
3 groups (13.4 ± 0.4 [sham control]; 13.1 ± 0.6 [C/IR];
10.5 ± 0.7 [TD/IR]; 13.4 ± 0.4 [TT/IR]). It is noteworthy
that inclusion of 3% b-alanine in the drinking water
usually reduces renal tissue taurine content of control
animals by about 50% [21]. Taken together, the data
s u g g e s tar e d u c e de f f i c a c yo fb-alanine to diminish kid-
ney taurine content during the recovery phase of the IR
insult.
A ss h o w ni nF i g u r e1 A ,b a s e l i n e( i . e . ,d a y0 )f l u i d
intake was slightly higher (p<0.05) in the TT/IR than in
the TD/IR group. Initiation of IR was associated with
greater water intake in the C/IR group. By contrast,
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intake. Six days after initiation of IR, daily water intake
was similar in the sham control and the TD/IR group,
but lower (p<0.05) than those of the C/IR and the TT/
IR groups. Baseline urine excretion was higher (p<0.05)
in the TT/IR group than in the other 3 groups, which
all showed similar values (Figure 1B, day 0). The initia-
tion of IR was associated with a significant increase in
daily urine excretion that peaked by day-2 followed by a
modest decline towards baseline values by day-6 after
initiation of IR, a pattern comparable in the control and
TT groups. By contrast, the TD/IR group showed a
slight and delayed (day-2) increase in urine excretion
followed by a return to the baseline value and that of
the sham control. The ratio of urine output/fluid intake
was significantly higher in the 3 IR groups than in sham
c o n t r o l ,ac h a r a c t e r i s t i cf e a t u r eo ft h ep o l y u r i cp h a s eo f
IR injury; this ratio was maximal at day-2 followed by
return to baseline values by day-6 post insult (Figure
1C). Baseline daily creatinine excretion was similar
among the groups. However, consistent with previous
reports indicating a transient decrease in creatinine
clearance [10], creatinine excretion was significantly
reduced in the 3 IR groups but rebounded towards base-
line values by day-6 post insult (Figure 1D).
Baseline urine osmolality was significantly higher in
the taurine deficient group compared to the other
groups (Figure 2, day 0) [18,21]. Since renal AQP 2 is
fundamental to the regulation of urine osmolality [24],
we determined protein abundance of the whole kidney
procured from control, taurine-deficient and taurine-
treated groups that had not been subjected to the IR
insult. As shown in Figure 3, taurine-deficient kidneys
showed significantly higher levels of non-glycosylated
(25 kD) and glycosylated (30-37 kD) forms of AQP 2
than the control and taurine treated groups, which both
showed similar AQP 2 levels.
Initiation of IR injury was associated with a similar,
marked decline in urine osmolality at day-1 post-insult
in control, taurine-deficient and taurine-treated groups
Figure 1 Daily metabolic parameters of experimental groups. Line graphs show daily water intake (A), daily urine excretion (B), the ratio of
urine output to water intake (C) and daily creatinine excretion (D) prior to (day 0) and after induction of bilateral renal ischemia reperfusion (IR)
injury in control (C/IR), taurine deficient (TD/IR) and taurine treated (TT/IR) as well as sham controls. Data are means ± SEM (n=5-7 animals/
group). * p< 0.05 compared to other groups at the same time point.
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IR and the TT/IR groups showed a similar, partial
recovery of urine osmolality, urine osmolality remained
significantly lower than their respective baseline values
at day-6 post insult. By contrast, the TD/IR group dis-
played an accelerated recovery, which commenced on
day-3; by day-6 post-insult, urine osmolality closely
approached the baseline pre-ischemic-reperfusion value
(Figure 2).
Daily proteinuria was similar in the groups prior to
initiation of IR or the sham procedure (i.e., day 0, Figure
4). The C/IR and TT/IR groups displayed a transient
increase in proteinuria (at day 1) which returned to
levels similar to the other 2 groups (e.g., days 2-4).
Nonetheless, the TD/IR group displayed a modestly
lower rate of protein excretion than the TT/IR group at
days 5-6 post insult (Figure 4). Analysis of the molecular
weight distribution of urinary proteins revealed the
appearance of albumin in the 3 IR groups compared to
the sham control group (Figure 4, day 6).
As shown in Figure 1B, daily urine excretion remained
higher at day-6 post-insult in the C/IR and TT/IR groups
Figure 2 Effects of a bilateral renal ischemia reperfusion insult
on urine osmolality. Line graphs show urine osmolality in
experimental groups as described under Figure 1. Data are means ±
SEM (n=5-7 animals/group). * p< 0.05 compared to other groups at
the same time point. ** p<0.05 compared to the TD/IR or the sham
controls.
Figure 3 Renal aquaporin (AQP)2 levels in taurine-treated and
taurine-deficient rats. The 25 kD and the 30-37 kD bands
represent non-glycosylated and glycosylated forms of AQP2,
respectively. Protein expression is expressed as percent of the
control group. Data are means ± SEM (n=3 animals/groups).
* p<0.05 compared to the other two groups.
Figure 4 Effects of a bilateral renal ischemia reperfusion insult
on urinary protein excretion. Line graphs show daily total protein
excretion in experimental groups as described under Figure 1; data
are means ± SEM (n=5-7 animals/group). Inset shows appearance of
albumin in urine of the 3 IR groups. Lane 1 shows molecular weight
standards (6.5-200kDa) while lane 2 is a sample of bovine serum
albumin from comparison (arrow). Lanes 3-10 show urinary protein
migration for the experimental groups as follows: 3-4 (sham
control), 5-6 (C/IR), 7-8 (TD/IR) and 9-10 (TT/IR). * p<0.05 C/IR and
TT/IR compared to the other two groups at the same time point.
Figure 5 Diuretic and natriuretic responses of experimental
groups to intravenous administration of a saline volume load.
Bar graphs show saline volume-induced diuretic and natriuretic
responses of experimental groups expressed as percent of the
administered fluid and sodium that were excreted over 90 minutes
after initiation of saline volume expansion (5% of body weight
administered over 30 minutes; i.v.). Data are means ± SEM (n=4
animals per group). *p<0.05 compared to other groups.
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post-insult, daily sodium excretion (mEq/day) was lower
in the TD/IR (0.6 ± 0.1) than in the other three groups
(1.3 ± 0.1 [sham control; p<0.05]; 1.0 ± 0.2 [C/IR]; 0.9 ±
0.2 [TT/IR]); potassium excretion (mEq/day) was
numerically lower in the TD/IR (2.6 ± 0.3) and the TT/
IR (3.1 ± 0.2) compared to the C/IR (3.7 ± 0.7) and sham
controls (3.8 ± 0.6) by day-6 post-insult. Thus, in order
to further assess the impact of IR injury on kidney
function, renal excretory responses to acute plasma
volume expansion were examined in conscious animals
(at day 10-11 post insult). The TD/IR group displayed a
significant reduction in saline volume-induced diuresis
and natriuresis compared to the other 3 groups, all of
which excreted similar percentages of the administered
loads (Figure 5). The baseline GFR was similar among
the groups (0.7-0.9 ml/min/g kidney weight). Analysis of
GFR and fractional excretion data indicate that increased
Figure 6 Histopathological features of renal tissue subjected to ischemia reperfusion insult. Panels show hematoxylin-eosin (H&E)
sections of kidneys from experimental groups at day-11 post-insult: panels A and B (sham control), C and D (C/IR), E and F (TD/IR) and G and H
(TT/IR).
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reduction in saline volume-induced diuresis and natriur-
esis in the TD/IR group (data not shown).
At the conclusion of the renal function studies, kidney
tissues were processed for light microscopic examina-
tion. As shown in Figure 6, the C/IR group showed per-
sistent foci of tubular necrosis despite recovery of
certain regions from the insult (panels C and D). Inter-
estingly, the TD/IR group (Figure 6; panels E-F) dis-
played features more closely resembling the sham
control group (panels A and B). In contrast to the other
two IR groups, the TT/IR group exhibited a predomi-
nance of tubules displaying cystic-like features (i.e.,
panels G and H; Figure 6). As shown in Figure 7, renal
tubules of TT/IR group displaying cystic dilatations
exhibited immunostaining for AQP1 (panel A) but not
AQP2 (panel B).
In light of these observations, as well as the demon-
stration of a similar decline in urinary concentrating
deficit in the 3 IR groups (i.e., day-1), morphological fea-
tures of kidneys were explored in additional rats at day-
1 post-ischemia reperfusion insult. While the cortical
region of the C/IR kidneys appeared relatively preserved,
the vast majority of tubules in the medullary regions
displayed sloughing, anucleated markedly eosinophilic
cells (Figure 8, panels A and D). The TD/IR group dis-
played morphological features resembling C/IR (i.e.,
apparent preservation of cortical tubules and glomeruli
but marked medullary tubular necrosis; Figure 8, panels
B and E). On the other hand, the TT/IR kidneys showed
diffuse cortical and medullary tubular necrosis but the
glomeruli appeared structurally intact (Figure 8, panels
C and F). Interestingly, the TT/IR group showed more
marked inflammatory cell infiltrates in renal tissue one
day after initiation of the IR insult, compared to the
TD/IR and C/IR groups, which showed moderate to
mild inflammatory infiltrates (Figure 8; arrows).
Apoptosis and cell proliferation are pivotal to the
recovery of the kidney from an IR insult [7-9,11].
Accordingly, we conjectured that the differential in
recovery of renal architecture in the three groups relates
to taurine-mediated modulation of proliferative capacity
and apoptosis. As shown in Figure 9, kidney sections
from control animals showed the lowest proliferative
foci (e.g., a single PCNA positive cell/tubule; Figure 9,
panel A). On the other hand, tissue sections from the
C/IR group showed clusters of PCNA positive cells (e.g.,
a range of 12-20 and an average of 16 PCNA positive
cells/tubule; Figure 9, panel B). Kidney sections from
TD/IR group showed a similar high proliferative cells of
varying intensity that appeared more spread throughout
renal parenchyma (Figure 9, panel C). On the other
hand, kidney sections from the TT/IR group showed
reduced proliferative foci (e.g., a range of 4-8 and an
average of 6 cells/tubule; Figure 9, panel D). The
TUNEL assay revealed foci of cellular, both nuclear and
cytoplasmic, staining mainly of tubular epithelial cells
and occasionally within interstitial space in all groups
(Figure 10). However, the sham control and C/IR group
showed the mildest reaction with only few scattered
positive single cells within occasional tubules (Figure
10A-10B). The TD/IR group showed mild to moderate
reaction with scattered foci of about one-to-two renal
tubular cell aggregates of positive cellular reaction (Fig-
ure 10C). A more intense reaction was observed in the
TT/IR group which showed several positive tubular
epithelial cells within morphologically normal renal
tubules juxtaposed to the areas of cystic dilation (Figure
10D).
Discussion
The present study shows that body taurine status is a
major determinant of renal IR injury. Taurine defi-
ciency increases both the extent and the rate of
Figure 7 Immunohistochemical localization of renal AQP1 and AQP2. Panel A shows immunostaining for AQP1 antibody (arrows) while
panel B shows immunostaining for AQP 2 in renal tissue of TT/IR group.
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with renal architecture resembling normal kidney. By
contrast, while taurine supplementation does not affect
functional recovery (e.g., urinary concentrating deficit)
from an IR insult, it unexpectedly causes marked
dilatation of renal tubules that resemble cyst forma-
tions. Taken together, the results show differential
effects of taurine deficiency and taurine treatment on
the outcome of renal IR insult. Importantly, to our
knowledge, this is the first demonstration of a marked
Figure 8 Histopathological features of the kidney from experimental groups. Panels show H&E sections of renal tissue from C/IR (A and D),
TD/IR (B and E) and TT/IR (C and F) groups one day after induction of ischemia reperfusion insult. Arrows point to inflammatory cell infiltrates.
Figure 9 Assessment of cell proliferation in renal tissue of experimental groups. Panels show immunofluoresence staining for proliferating
cell nuclear antigen of renal tissue from sham control (A), C/IR (B), TD/IR (C) and TT/IR (D).
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a pathological condition.
A number of studies have reported beneficial effects of
taurine treatment on renal function and structure in
chronic renal dysfunction/failure [25-28,19,20]. How-
ever, very limited information is available in relation to
t a u r i n ea n da c u t er e n a lf a i l u r es e c o n d a r yt oi s c h e m i c
injury. One study examined the effect of taurine on
40 minutes of bilateral renal ischemia followed by 6
hours of reperfusion [29]. Based on examination of sev-
eral plasma markers and renal architecture, the authors
concluded that taurine treatment reduces renal IR
injury. Nonetheless, in that study, taurine was delivered
intraperitoneally during the initiation of the IR insult,
making it difficult to discern its bioavailability. A more
recent study examined the impact of taurine precondi-
tioning of the rat donor kidney; taurine preconditioning
was achieved by treatment of the rat for 19 hrs. with
taurine prior to donor nephrectomy [30]. Following
transplantation, the taurine preconditioned kidney was
resistant to injury (apoptosis and necrosis) relative to
the untreated kidney. Thus, taurine treatment improved
graft function during recovery. Nonetheless, both studies
examined the impact of taurine supplementation during
an early phase of reperfusion (i.e., 6 hrs). These benefi-
cial effects resemble the cytoprotective activity of taurine
noted in other acute studies, which were attributed to
osmoregulation, antioxidation, membrane stabilization,
conjugation and regulation of [Ca
2+]i[14]. However, the
present study focused on the chronic effects of taurine,
which are particularly relevant to recovery of the kidney
from IR insult.
A major finding of this study is the differential effect
of body taurine status on urinary concentrating ability
of the ischemic reperfused kidney. While the initial
decline in urine osmolality was similar in the 3 IR
groups, the TT/IR group displayed a gradual, partial
recovery of urine osmolality, which resembled that of
the C/IR group. By contrast, the TD/IR group displayed
an accelerated, more marked recovery of urinary con-
centrating ability than that of either the C/IR or the
TT/IR group. Interestingly, the recovery of urine osmol-
ality in the taurine deficient condition is more promi-
nent than has been shown for other maneuvers (e.g.,
erythropoietin) [31]. A likely contributing factor to the
urinary concentrating ability of the post-ischemic kidney
relates to dysregulation of renal tubule solute transpor-
ters and water channels (i.e., aquaporins) [31,32].
Indeed, expression of aquaporins 2 and 3 in the collect-
i n gd u c t s ,a sw e l la se x p r e s s i o no fa q u a p o r i n1i nt h e
proximal tubules, are significantly reduced in acute
renal failure occurring secondary to the IR insult
[31,32]. Thus, it is plausible that taurine deficiency mod-
ulates the expression of aquaporins (and/or solute trans-
porters), thereby contributing to a more robust recovery
of the urinary concentrating ability. In support of this
notion, we now show that the increased baseline urine
osmolality is indeed associated with an increase in the
Figure 10 Assessment of apoptosis in renal tissue of experimental groups. The TUNEL assay reveals greater apoptotic foci (arrow) in the
TT/IR (panel D) than the TD/IR (panel C) group; the sham control (panel A) and C/IR (panel B) showed similar, but lower, foci than the TD/IR and
TT/IR groups.
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arginine vasopressin (AVP) and contributes to the
increase in water permeability of the collecting ducts
[24]. Collectively, these observations, along with the
finding that taurine deficiency increases plasma AVP
levels [18], provide compelling evidence for the working
hypothesis that taurine deficiency modulates the urinary
concentrating mechanism through effects mediated by
the release and subsequent renal actions of AVP. Inter-
estingly, however, taurine supplementation does not sig-
nificantly affect plasma AVP, urine osmolality [18] or
renal aquaporin2 expression.
Another striking, albeit unexpected, difference
between the taurine-treated and taurine deficient rats
relates to recovery of renal structure from the IR insult.
While TD/IR kidneys displayed features resembling
sham controls, kidneys of TT/IR rats showed cystic dila-
tation of renal tubules. Immunostaining studies using
antibodies against renal AQP 1 and 2 suggest a proximal
tubule origin for the markedly dilated tubules in the kid-
neys of TT/IR group; while AQP2 is localized to the dis-
tal portions of the nephron, AQP1 is localized to the
straight proximal tubules and the early segments of the
descending loop of Henle [24]. Thus, it appears that
taurine treatment disrupts the normal processes that are
involved in the regeneration of the proximal tubules by
altering the phenotype of the proximal tubular cells.
These cells, which line the markedly dilated tubules,
appear flattened and generally lack brush borders.
Cell volume regulation is critical to both cell prolifera-
tion and apoptosis, processes that determine the out-
come of an IR insult to the kidney [33,34]. While cell
proliferation requires an increase in cell volume, cell
shrinkage is a hallmark feature of apoptosis. Nonethe-
less, appropriate changes in cell volume under any given
condition are dependent on the participation of cell
volume regulatory mechanisms [33-36,14]. Taurine is a
very important organic osmolyte in mammalian cells,
including those of the kidney. It is a major contributor
to regulatory volume processes, such as the regulatory
volume decrease and increase, which modulate cell
volume and cell membrane stress following exposure of
the cell to hypoosmotic and hyperosmotic milieu,
respectively [14]. These cellular regulatory volume
changes are achieved by ion channels (e.g., Na
+,C l
-) and
transporters, including the taurine cotransporter (stoi-
chiometry of 2Na
+,1 C l
-; 1 taurine) [35,14]. Similarly,
diverse apoptotic stimuli are known to activate Cl
- chan-
nels and promote organic osmolyte release (e.g., taurine)
[33,34]. Taurine is intimately involved in regulation of
these events and the status of the cell in relation to its
organic osmolyte content can be of consequence for
both cell proliferation and apoptosis. This is reflected
from the results of this study which show differential
effects of taurine deficiency and treatment on cell prolif-
eration and apoptosis. The TD/IR group displayed more
proliferative foci but reduced apoptosis while the TT/IR
group showed greater apoptosis but reduced prolifera-
tive index. A simple explanation may relate to exposure
of renal tubule cells to hyperosmolar urine in the TD/IR
than hyposomolar urine in the TT/IR group thereby
evoking the regulatory volume increase vs. regulatory
volume decrease processes, respectively. Consequently,
the evoked regulatory volume increase should favor cell
swelling and proliferation in the TD/IR group while the
regulatory volume decrease in the TT/IR should favor
cell shrinkage and apoptosis.I m p o r t a n t l y ,h o w e v e r ,
assessment of cell proliferation and apoptosis were car-
ried out 11 days after initiation of IR insult. Thus future
assessment of the influence of body taurine status on
temporal changes in cell proliferation and apoptosis in
the kidney which is recovering from an IR insult in rela-
tion to cell volume regulatory mechanisms is warranted.
Changes in intracellular taurine content not only
influence cell proliferation and apoptosis, but also the
cellular composition of other osmolytes. This is under-
standable since the same transcription factor (i.e.,
TonEBP/OREBP) regulates transporters and enzymes
that participate in cellular accumulation of organic
osmolytes [37]. However, if loss of one organic osmolyte
was adequately compensated for by another organic
osmolyte, one would likely not expect to detect altera-
tions in function/structure of the organ (e.g., the kidney)
that relies so heavily on organic osmolytes to cope with
hypertonicity of the medullary interstitium [14,20,21].
Yet the present study demonstrates that taurine deple-
tion seemingly benefits the IR kidney. It is noteworthy
that taurine depletion also benefits the IR myocardium
[38]. The cardioprotective effect of taurine deficiency
may relate, in part, to osmotic preconditioning and acti-
vation of prosurvival pathways [39] but their relevance
to recovery of the TD/IR kidney remains to be
established.
Taurine is known to modulate/regulate inflammatory
and immune-mediated processes, aspects that are of par-
ticular relevance to the IR kidney. For example, taurine
reacts with hypochlorous acid to form taurine chlora-
mines, a reaction catalyzed by neutrophil myeloperoxi-
dase [40,41]. Taurine chloramine is less toxic and more
stable than hypochlorous acid and has been shown to
down-regulate the production of pro-inflammatory med-
iators in leukocytes obtained from human and rodents.
This is achieved, in part, by inhibition of nuclear factor-
B, a potent signal transducer of inflammatory cytokines
[40]. Thus, the lack of a beneficial effect of taurine treat-
ment on the function of the ischemic reperfused kidney
is inconsistent with a major role for taurine chloramines
in the TT/IR kidney. In fact, the propensity for renal
Mozaffari et al. Journal of Biomedical Science 2010, 17(Suppl 1):S32
http://www.jbiomedsci.com/content/17/S1/S32
Page 10 of 12tubules to resemble cyst formations suggests that taurine
treatment adversely affects the outcome of the IR insult.
On the other hand, taurine deficiency improved renal
structure and function post-insult. The reasons for these
seemingly paradoxical observations are not apparent
from this study. However, it is noteworthy that a number
of reports indicate that interruption of inflammatory and
immune-mediated processes is beneficial for the recovery
of the kidney from an ischemic insult [42,43]. Indeed, the
beneficial effect of preconditioning is attributed to the
decreased capacity of immune cells to cause tissue injury
(43). In addition, administration of anti-CD44 to mice
reduces the influx of neutrophils into the postischemic
tissue which is associated with the preservation of renal
function [42]. Interestingly, the TT/IR group showed
more marked inflammatory cell infiltrates in renal tissue
one day after induction of IR injury compared to the TD/
IR and C/IR which showed moderate and mild inflamma-
tory infiltrates, respectively. Thus further studies should
explore taurine modulation of inflammatory responses in
the setting of renal ischemia reperfusion injury.
Conclusions
Taurine treatment and taurine deficiency exert differen-
tial effects on the outcome of a renal IR insult. While
taurine deficiency seeming benefits the IR kidney, taur-
ine treatment does not affect functional recovery
although examination of renal architecture reveals
dilated tubules throughout the renal parenchyma. Given
multiple actions of taurine [14,15,39,40], its deficiency is
not a desirable clinical objective. Rather, unraveling of
mechanisms of taurine modulation of the IR kidney
should enhance our understanding of the role of this
ubiquitous but underappreciated renal osmolyte, aspects
of potential clinical relevance.
Abbreviations
AVP: Arginine vasopressin; AQP: Aquaporin; C: Control; GFR: Glomerular
filtration rate; H & E: Hematoxylin-eosin; IR: Ischemia reperfusion; PCNA:
Proliferating cell nuclear antigen; SDS-PAGE: Sodium dodecyl sulfate
polyacrylamide gel electrophoresis; TD: Taurine deficient; TT: Taurine-treated;
TUNEL: Terminal deoxynucleotidyl transferase dUTP nick end labeling.
Acknowledgements
This article has been published as part of Journal of Biomedical Science
Volume 17 Supplement 1, 2010: Proceedings of the 17th International
Meeting of Taurine. The full contents of the supplement are available online
at http://www.jbiomedsci.com/supplements/17/S1.
This study was supported, in part, by research incentive funds from the
Medical College of Georgia Research Institute.
Author details
1Department of Oral Biology, Medical College of Georgia School of Dentistry,
Augusta, Georgia 30912, USA.
2Department of Oral Health and Diagnostic
Sciences, Medical College of Georgia School of Dentistry, Augusta, Georgia
30912, USA.
3Department of Pharmacology, University of South Alabama
Mobile, Alabama 36688, USA.
Authors’ contributions
MSM is responsible for the design and overall conduct of the study and
preparation of the manuscript. RA carried out histopathological examination
of tissue samples. CP, HW and JYL conducted the research (80%, 10% and
10%, respectively). SWS provided valuable comments on the manuscript.
Competing interests
The authors declare that they have no competing interests.
Published: 24 August 2010
References
1. Fry AC, Farrington K: Management of acute renal failure. Postgrad Med J
2006, 82:106-116.
2. Spurgeon-Pechman KR, Donohoe DL, Mattson DL, Lund H, James L,
Basile DP: Recovery from acute renal failure predisposes hypertension
and secondary renal disease in response to elevated sodium. Am J
Physiol Renal Physiol 2007, 293:F269-F278.
3. Torras J, Herrero-Fresneda I, Lloberas N, Riera M, Ma Cruzado J, Ma Grinyό J:
Promising effects of ischemic preconditioning in renal transplantation.
Kidney Int 2002, 61:2218-2227.
4. Szwarc I, Garrigue V, Delmas S, Deleuze S, Chong G, Mourad G: Delayed
graft function: a frequent but still unsolved problem in renal
transplantation. Nephrol Ther 2005, 1(6):325-334.
5. Velic A, Gabriëls G, Hirsch JR, Schröter R, Edemir B, Paasche S, Schlatter E:
Acute rejection after rat renal transplantation leads to downregulation
of NA+ and water channels in the collecting duct. Am J Transplant 2005,
5(6):1276-1285.
6. Boros P, Bromberg JS: New cellular and molecular immune pathways in
ischemia/ reperfusion injury. Am J Transplant 2006, 6:652-658.
7. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions,
diagnosis, pathogenesis, and therapy. J Clin Invest 2004, 114:5-14.
8. Liu KD: Molecular mechanisms of recovery from acute renal failure. Crit
Care Med 2003, 31(8):S572-S581.
9. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of
ischemic acute renal failure. J Am Soc Nephrol 2003, 14:2199-2210.
10. Basile DP, Donohoe D, Roethe K, Osborn JL: Renal ischemic injury results
in permanent damage to peritubular capillaries and influences long-
term function. Am J Physiol Renal Physiol 2001, 281:F887-F899.
11. Devarajan P: Cellular and molecular derangements in acute tubular
necrosis. Curr Opin Pediatr 2005, 17:193-199.
12. Lin F: Stem cells in kidney regeneration following acute renal injury.
Pediatr Res 2006, 59:74R-78R.
13. Krause D, Cantley LG: Bone marrow plasticity revisited: protection of
differentiation in the kidney tubule? J Clin Invest 2005, 115:1705-1708.
14. Schaffer SW, Azuma J, Takahashi K, Mozaffari MS: Why is taurine
cytoprotective? Adv Exp Med Biol 2003, 526:307-321.
15. Bouckenooghe T, Remacle C, Reusens B: Is taurine a functional nutrient?
Curr Opin Clin Nutr Metab Care 2006, 9:728-733.
16. Takatani T, Takahashi K, Uozumi Y, Shikata E, Yamamoto Y, Ito T, Matsuda T,
Schaffer SW, Azuma J: Taurine inhibits apoptosis by preventing formation
of the Apaf-1/caspase-9 apoptosome. Am J Physiol Cell Physiol 2004, 287:
C949-953.
17. Takatani T, Takahashi K, Uozumi Y, Matsuda T, Ito T, Schaffer SW, Fujio Y,
Azuma J: Taurine prevents the ischemia-induced apoptosis in cultured
neonatal rat cardiomyocytes through Akt/caspase-9 pathway. Biochem
Biophys Res Commun 2004, 316:484-489.
18. Mozaffari MS, Schaffer D: Taurine modulates arginine vasopressin-
mediated regulation of renal function. J Cardiovasc Pharm 2001,
37:742-750.
19. Mozaffari MS, Miyata N, Schaffer SW: Effects of taurine and enalapril on
kidney function in the hypertensive glucose-intolerant rat. Am J
Hypertens 2003, 16:673-680.
20. Mozaffari MS, Schaffer SW: Chronic taurine treatment ameliorates
reduction in saline-induced diuresis and natriuresis. Kidney Int 2002,
61:1750-1759.
21. Mozaffari MS, Patel C, Abdelsayed R, Schaffer SW: Accelerated NaCl-
induced hypertension in taurine deficient rat: Role of renal function.
Kidney Int 2006, 70(2):329-337.
Mozaffari et al. Journal of Biomedical Science 2010, 17(Suppl 1):S32
http://www.jbiomedsci.com/content/17/S1/S32
Page 11 of 1222. Mozaffari MS, Abdelsayed R, Liu JY, Wimborne H, El-Remessy A, El-
Marakby A: Effects of chromium picolinate on glycemic control and
kidney of the obese Zucker rat. Nutr Metab (Lond). 2009, 6:51.
23. Kim D, Sands JM, Klein JD: Role of vasopressin in diabetes mellitus-
induced changes in medullary transport proteins involved in urine
concentration in Brattleboro rats. Am J Physiol Renal Physiol 2004, 286(4):
F760-766.
24. Nielsen S, Kwon TH, Frøkiaer J, Agre P: Regulation and dysregulation of
aquaporins in water balance disorders. J Intern Med 2007, 261:53-64.
25. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A,
Tarectecan AA, Rao PS, Sturman JA, Boles TH, et al: Taurine ameliorates
chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol
1995, 269(3 Pt 2):F429-38.
26. Trachtman H, Sturman JA: Taurine and experimental kidney disease. Adv
Exp Med Biol 1994, 359:149-57.
27. Trachtman H, Del Pizzo R, Futterweit S, Levine D, Rao PS, Valderrama E,
Sturman JA: Taurine attenuates renal disease in chronic puromycin
aminonucleoside nephropathy. Am J Physiol 1992, 262(1 Pt 2):F117-23.
28. Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J: Hypoglycemic,
antioxidative and nephroprotective effects of taurine in alloxan diabetic
rabbits. Biochimie 2008, 91(2):261-270.
29. Guz G, Oz E, Lortlar N, Ulusu NN, Nurlu N, Demirogullari B, Omeroglus S,
Sert S, Karasu C: The effect of taurine on renal ischemia/reperfusion
injury. Amino Acids 2007, 32:405-411.
30. Guan X, Dei-Anane G, Liang R, Gross ML, Nickkholgh A, Kern M, Ludwig J,
Zeier M, Büchler NN, Schmidt J, Schemmer P: Donor preconditioning with
taurine protects kidney grafts from injury after experimental
transplantation. JS u r gR e s2008, 146(1):127-134.
31. Gong H, Wang W, Kwon TH, Jonassen J, Li C, Ring T, FrökiAEr J, Nielsen S:
EPO and a-MSH prevent ischemia/reperfusion-induced down-regulation
of AQPs and sodium transporters in rat kidney. Kidney Int 2004,
66:683-695.
32. Kwon TH, Frøkiaer J, Han JS, Knepper MA, Nielsen S: Decreased abundance
of major Na(+) transporters in kidneys of rats with ischemia-induced
acute renal failure. Am J Physiol Renal Physiol 2000, 278(6):F925-F939.
33. Lang F, Gulbins E, Szabo I, Lepple-Wienhues A, Huber SM, Duranton C,
Lang KS, Lang PA, Wieder T: Cell volume and the regulation of apoptotic
cell death. J Mol Recognit 2004, 17:473-480.
34. Lang F, Foller M, Lang KS, Lang PA, Ritter M, Gulbins E, Vereninov A,
Juber SM: Ion channels in cell proliferation and apoptotic cell death. J
Membr Biol 2005, 205:147-157.
35. Han X, Patters AB, Jones DP, Zelikovic I, Chesney RW: The taurine
transporter: mechanisms of regulation. Acta Physiol (Oxf) 2006, 187:61-73.
36. Lang J, Madlung D, Siemen C, Lang F, Madlung J, Siemen D, Ellory C,
Lepple-Wienhues A, Gulbins E: The involvement of caspases in the CD95
(Fas/Apo-1) but not swelling-induced cellular taurine release from Jurkat
T-lymphocytes. Pflugers Arch 2000, 440:93-99.
37. Burg MB, Ferraris JD, Dmitrieva NI: Cellular response to hyperosmotic
stresses. Physiol Rev 2007, 87(4):1441-1474.
38. Allo SN, Bagby L, Schaffer SW: Taurine depletion, a novel mechanism for
cardioprotection from regional ischemia. Am J Physiol 1997, 273(4 Pt 2):
H1956-61.
39. Pastukh V, Ricci C, Solodushko V, Mozaffari M, Schaffer SW: Contribution of
the PI3-kinase/Akt survival pathway toward osmotic preconditioning.
Mol Cell Biochem 2005, 269(12):59-67.
40. Schuller-Levis GB, Park E: Taurine and its chloramine: modulators of
immunity. Neurochem Res 2004, 29:117-126.
41. Mainnemare A, Megarbane B, Soueidan A, Daniel A, Chapple IL:
Hypochlorous acid and taurine-N-monochloramine in periodontal
disorders. J Dent Res 2004, 83(11):823-831.
42. Rouschop KM, Roelofs JJ, Claessen N, da Costa Martins P, Zwaginga JJ,
Pals ST, Weening JJ, Florquin S: Protection against renal ischemia
reperfusion injury by CD44 disruption. J Am Soc Nephrol 2005,
16:2034-2043.
43. Burne-Taney MJ, Liu M, Baldwin WM, Racusen L, Rabb H: Decreased
capacity of immune cells to cause tissue injury mediates kidney
ischemic preconditioning. J Immunol 2006, 176:7015-7020.
doi:10.1186/1423-0127-17-S1-S32
Cite this article as: Mozaffari et al.: Differential effects of taurine
treatment and taurine deficiency on the outcome of renal ischemia
reperfusion injury. Journal of Biomedical Science 2010 17(Suppl 1):S32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mozaffari et al. Journal of Biomedical Science 2010, 17(Suppl 1):S32
http://www.jbiomedsci.com/content/17/S1/S32
Page 12 of 12